Related Experiment Video
Updated: Jul 10, 2026
04:50
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Disease activity measures for rheumatoid arthritis
M Dougados1, D Aletaha, P van Riel
1Hopital Cochin, Descartes University, Service de Rhumatologie B, Paris, France. maxime.dougados@cch.ap-hop-paris.fr
Clinical and Experimental Rheumatology
|November 21, 2007
Summary
Effective rheumatoid arthritis (RA) management requires precise disease activity assessment. Combining optimal treatment strategies with appropriate outcome measures, like composite indices, is key for patient benefit and achieving remission.
Area of Science:
- Rheumatology and Immunology
- Clinical Trial Design
- Disease Management
Background:
- Rheumatoid arthritis (RA) is a progressive autoimmune disease causing irreversible joint damage and functional loss.
- Accurate assessment of disease activity over time is crucial for managing RA and evaluating treatment efficacy.
- Current composite indices (e.g., DAS28, CDAI, RADAI) offer comprehensive disease activity views.
Purpose of the Study:
- To review the importance of time-inclusive measures for assessing rheumatoid arthritis disease activity.
- To discuss the selection of appropriate composite indices for clinical practice versus clinical trials.
- To highlight novel monitoring strategies and their role in optimizing RA treatment.
Main Methods:
- Review of composite indices used in rheumatoid arthritis assessment.
- Discussion of disease monitoring strategies and their impact on treatment optimization.
- Analysis of the interplay between treatment strategies and outcome measures.
Main Results:
- Composite indices provide a comprehensive view of rheumatoid arthritis disease activity.
- Different indices have varying applicability in clinical practice and trials.
- Intensive monitoring and rapid treatment adjustments may offer significant patient benefit.
Conclusions:
- The choice of assessment index should align with its intended use (clinical practice vs. trials).
- Combining optimal treatment with appropriate outcome measures maximizes patient benefit in RA.
- Further research is needed to fully evaluate the clinical relevance of RA assessment methods.
Related Concept Videos
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:20Rheumatic Heart Disease IV: Nursing Management
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...